Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

ABSTRACT: Purpose In 2016, ASCO published a guideline to assist in clinical decision making in metastatic pancreatic cancer for initial assessment after diagnosis, first- and second-line treatment options, palliative and supportive care, and follow-up. The purpose of this update is to incorporate new evidence related to second-line therapy for patients who have experienced disease progression or intolerable toxicity during first-line therapy. Methods ASCO convened an Expert Panel to conduct a systematic review of the literature on second-line therapy published between June 2015 and January 2018. Recommendations on other topics covered in the 2016 Metastatic Pancreatic Cancer Guideline were endorsed by the Expert Panel. Results Two new studies were found that met the inclusion criteria. Recommendatio

SUBMITTER: Sohal DPS 

PROVIDER: S-EPMC7504972 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature